Daiwa Securities Group’s Wave Life Sciences WVE Stock Holding History

Daiwa Securities Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-503	Closed	-$9K	–	1452
2025 Q4	$9K	Hold	503	–	–	﹤0.01%	1197
2025 Q3	$4K	Hold	503	–	–	﹤0.01%	1230
2025 Q2	$3K	Hold	503	–	–	﹤0.01%	1200
2025 Q1	$4K	Hold	503	–	–	﹤0.01%	1156
2024 Q4	$6K	Buy	503 +154	+44%	+$2.06K	﹤0.01%	1157
2024 Q3	$3K	Hold	349	–	–	﹤0.01%	1208
2024 Q2	$2K	Hold	349	–	–	﹤0.01%	1271
2024 Q1	$2K	Hold	349	–	–	﹤0.01%	1282
2023 Q4	$2K	Hold	349	–	–	﹤0.01%	1284
2023 Q3	$2K	Hold	349	–	–	﹤0.01%	1230
2023 Q2	$1K	Hold	349	–	–	﹤0.01%	1305
2023 Q1	$2K	Hold	349	–	–	﹤0.01%	1230
2022 Q4	$2K	Buy	349 +250	+253%	+$1.15K	﹤0.01%	1243
2022 Q3	$0	Hold	99	–	–	﹤0.01%	1407
2022 Q2	$0	Hold	99	–	–	﹤0.01%	1435
2022 Q1	$0	Hold	99	–	–	﹤0.01%	1424
2021 Q4	$0	Hold	99	–	–	﹤0.01%	1452
2021 Q3	$0	Hold	99	–	–	﹤0.01%	1345
2021 Q2	$1K	Hold	99	–	–	﹤0.01%	1220
2021 Q1	$1K	Hold	99	–	–	﹤0.01%	1232
2020 Q4	$1K	Sell	99 -114	-54%	-$957	﹤0.01%	1211
2020 Q3	$2K	Hold	213	–	–	﹤0.01%	1148
2020 Q2	$32K	Hold	213	–	–	﹤0.01%	984
2020 Q1	$2K	Hold	213	–	–	﹤0.01%	1169
2019 Q4	$1K	Hold	213	–	–	﹤0.01%	1191
2019 Q3	$4K	Hold	213	–	–	﹤0.01%	1096
2019 Q2	$6K	Hold	213	–	–	﹤0.01%	1086
2019 Q1	$8K	Sell	213 -24	-10%	-$974	﹤0.01%	1048
2018 Q4	$10K	Buy	+237	New	+$10.5K	﹤0.01%	999

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

GSK plc London $602M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Daiwa Securities Group's WVE Position: Q1 2026 in Review

Daiwa Securities Group sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 503 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in WVE in Q4 2018 and held it in 29 quarters. The position peaked at $32K in Q2 2020. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Daiwa Securities Group reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 503 Wave Life Sciences shares in Q1 2026, an estimated $9K.
Daiwa Securities Group first reported a position in Wave Life Sciences in Q4 2018 and held it in 29 quarters.
Daiwa Securities Group's Wave Life Sciences position peaked at $32K in Q2 2020.
232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.